Application Note: Mass detection: The key to faster biopharma analysis
11 October 2019

As the biopharmaceutical industry continues to grow and expand into new and ever more complex modalities, biopharmaceutical developers and manufacturers are in urgent need of optimized analytical solutions. This application-based compendium is intended as a resource for anyone in biopharmaceutical development, manufacturing, and QC who wishes to streamline their drug development, accelerate time-to-market, and enable greater productivity in the laboratory.

Download this eBook to find more about the biopharmaceutical applications of the ACQUITY QDa Mass Detector and the BioAccord system from Waters, including:

  • Increasing specificity and sensitivity in routine peptide analyses 
  • LC-UV-MS-based synthetic peptide identification and impurity profiling
  • Improving glycan profiling in process development
  • Monitoring multiple attributes in a single assay
  • Enabling routine & reproducible intact mass analysis when data integrity matters
  • An integrated peptide attribute profiling and monitoring workflow for improved productivity
  • A platform method for the molecular mass analysis of the light & heavy chains of monoclonal antibodies
  • Increasing productivity and confidence for N-linked glycan analysis of biosimilars